Intra-ampullary papillary-tubular neoplasm (IAPN): Characterization of tumoral intraepithelial neoplasia occurring within the ampulla: A clinicopathologic analysis of 82 cases

American Journal of Surgical Pathology

Volumn 34, Issue 12, 2010, Pages 1731-1748

  Ohike, Nobuyuki ^a   Kim, Grace E ^b   Tajiri, Takuma ^c   Krasinskas, Alyssa ^d   Basturk, Olca ^e   Coban, Ipek ^a   Bandyopadhyay, Sudeshna ^f   Morohoshi, Toshio ^a   Goodman, Michael ^g   Kooby, David A ^h   Sarmiento, Juan M ^h   Adsay, N Volkan ^a  

^a SHOWA UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g EMORY UNIVERSITY   (United States)

^h EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

ampulla; ampullary; intra ampullary; papillary; tubular; tumoral intraepithelial neoplasia

Indexed keywords

TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT TUMOR; CARCINOMA IN SITU; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PANCREATICODUODENECTOMY; PATHOLOGY; SURVIVAL RATE; UNITED STATES; VATER PAPILLA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; CARCINOMA IN SITU; COMMON BILE DUCT NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 78650309616     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181f8ff05     Document Type: Article

References (71)

1. Adsay NV, Kloppel G, Fukushima N, et al. Intraductal neoplasms of the exocrine pancreas. In: Bosman FT, Carneiro F, Hruban RH, et al, eds. World Health Organization Classification of Tumours of the Digestive System. Geneva: WHO Press; (in press).
2. Abraham SC, Lee JH, Boitnott JK, et al. Microsatellite instability in intraductal papillary neoplasms of the biliary tract. Mod Pathol. 2002;15:1309-1317.
3. Abraham SC, Lee JH, Hruban RH, et al. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol. 2003;34:902-910.
4. Adsay NV, Klimstra DS. Benign and malignant tumors of the gallbladder and extrahepatic biliary tract. In: Odze RD, Goldblum JR, eds. Surgical Pathology of the GI tract, Liver, Biliary Tract, and Pancreas. Philadelphia: Elsevier; 2009:845-875.
5. Adsay NV, Adair CF, Heffess CS, et al. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol. 1996;20: 980-994.
6. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002;15:1087-1095.
7. Adsay NV, Merati K, Nassar H, et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol. 2003;27:571-578.
8. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol. 2004;28:839-848.
9. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the gallbladder, extrahepatic bile ducts, and ampulla of Vater. Atlas of Tumor Pathology. 3rd ed. Washington DC: Armed Forces Institute of Pathology; 2000:245-258.
10. Albores-Saavedra J, Murakata L, Krueger JE, et al. Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer. 2000;89:508-515.
11. Albores-Saavedra J, Schwartz AM, Batich K, et al. Cancers of the ampulla of vater: demographics, morphology, and survival based on 5625 cases from the SEER program. J Surg Oncol. 2009;100:598-605.
12. Alexander JR, Andrews JM, Buchi KN, et al. High prevalence of adenomatous polyps of the duodenal papilla in familial adenoma-tous polyposis. Dig Dis Sci. 1989;34:167-170.
13. Bal A, Joshi K, Vaiphei K, et al. Primary duodenal neoplasms: a retrospective clinicopathological analysis. World J Gastroenterol. 2007;13:1108-1111.
14. Basturk O, Coban I, Adsay NV. Pancreatic cysts: pathologic classification, differential diagnosis, and clinical implications. Arch Pathol Lab Med. 2009;133:423-438.
15. Basturk O, Farris AB, Adsay NV. Immunohistology of pancreas, gallbladder, extrahepatic bile ducts, ampulla and liver. In: Dabbs D, ed. Diagnostic Immunohistochemistry. 3rd ed. Philadelphia: Saunders Elsevier; 2010:541-592.
16. Basturk O, Khayyata S, Klimstra DS, et al. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway in pancreatic carcinogenesis, distinct from the intestinal pathway. Am J Surg Pathol. 2010;34:364-370.
17. Cathro HP, Stoler MH. Expression of cytokeratins 7 and 20 in ovarian neoplasia. Am J Clin Pathol. 2002;117:944-951.
18. Cavallini M, Cavaniglia D, Felicioni F, et al. Large periampullary villous tumor of the duodenum. J Hepatobiliary Pancreat Surg. 2007;14:526-528.
19. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962-972.
20. Dursun N, Roa JC, Tapia O, et al. Intravesicular papillary-tubular neoplasm (IVPN) as a unifying category for mass forming preinvasive neoplasms of the gallbladder: an analysis of 87 cases. Mod Pathol. 2010;23:144A.
21. Duval JV, Savas L, Banner BF. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladder. Arch Pathol Lab Med. 2000;124:1196-1200.
22. Furukawa T, Kloppel G, Adsay NV, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794-799.
23. Goldstein NS, Bassi D. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold. Am J Clin Pathol. 2001;115:695-702.
24. Hartenfels IM, Dukat A, Burg J, et al. Adenomas of Vater's ampulla and of the duodenum, presentation of diagnosis and therapy by endoscopic interventional and surgical methods. Chirurg. 2002;73:235-240.
25. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-987.
26. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas. AFIP Atlas of Tumor Pathology. 4th series, Fascicle 6. Washington, DC: American Registry of Pathology; 2007:75-110.
27. Ji H, Isacson C, Seidman JD, et al. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol. 2002;21:391-400.
28. Kim HJ, Kim MH, Lee SK, et al. Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy. 2000;32:389-393.
29. Klimstra DS, Adsay NV. Tumors of the pancreas and ampulla vater. In: Odze RD, Goldblum JR, eds. Surgical Pathology of the GI tract, Liver, Biliary Tract, and Pancreas. Philadelphia: Elsevier; 2009:845-876.
30. Klimstra DS, Adsay NV. Tumors of the pancreas and ampulla of vater. In: Odze RD, Goldblum JR, eds. Surgical Pathology of the GI tract, Liver, Biliary Tract, and Pancreas. Philadelphia: Elsevier; 2009:909-962.
31. Klimstra DS, Adsay NV, Dhall D, et al. Intraductal tubular carcinoma of the pancreas: clinicopathologic and immunohisto-chemical analysis of 18 cases. Mod Pathol. 2007;20:285A.
32. Kloppel G, Kosmahl M. Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm? J Hepatol. 2006;44:249-250.
33. Kloppel G, Solcia E, Longnecker DS, et al. Histologic Typing of Tumors of the Exocrine Pancreas. Geneva: Springer; 1996.
34. Lee MJ, Lee HS, Kim WH, et al. Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol. 2003;16:403-410.
35. Levi E, Klimstra DS, Andea A, et al. MUC1 and MUC2 in pancreatic neoplasia. J Clin Pathol. 2004;57:456-462.
36. Li MK and, Folpe AL. CDX-2, a new marker for adenocarcinoma of gastrointestinal origin. Adv Anat Pathol. 2004;11:101-105.
37. Lim JH, Yi CA, Lim HK, et al. Radiological spectrum of intraductal papillary tumors of the bile ducts. Korean J Radiol. 2002;3:57-63.
38. Lim JH, Jang KT, Rhim H, et al. Biliary cystic intraductal papillary mucinous tumor and cystadenoma/cystadenocarcinoma: differentiation by CT. Abdom Imaging. 2007;32:644-651.
39. Longnecker DS, Adler G, Hruban RH, et al. Intraductal papillary mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000:237-243.
40. Luttges J, Zamboni G, Longnecker D, et al. The immunohisto-chemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol. 2001;25:942-948.
41. Moskaluk CA, Zhang H, Powell SM, et al. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol. 2003;16:913-919.
42. Nagata K, Horinouchi M, Saitou M, et al. Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg. 2007;14:243-254.
43. Nakamura A, Horinouchi M, Goto M, et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J Pathol. 2002;197:201-210.
44. Noffsinger A. Epithelial neoplasms of the small intestine. In: Odze RD, Goldblum JR, eds. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. Philadelphia: Saunders; 2009:581-596.
45. Odze R, Gallinger S, So K, et al. Duodenal adenomas in familial adenomatous polyposis: relation of cell differentiation and mucin histochemical features to growth pattern. Mod Pathol. 1994;7:376-384.
46. Oshikiri T, Kashimura N, Katanuma A, et al. Mucin-secreting bile duct adenoma-clinicopathological resemblance to intraductal papillary mucinous tumor of the pancreas. Dig Surg. 2002;19:324-327.
47. Poultsides GA, Reddy S, Cameron JL, et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg. 2010;251:470-476.
48. Rouzbahman M, Serra S, Adsay NV, et al. Oncocytic papillary neoplasms of the biliary tract: a clinicopathological, mucin core and Wnt pathway protein analysis of four cases. Pathology. 2007;39:413-418.
49. Rullier A, Le Bail B, Fawaz R, et al. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol. 2000;24:870-876.
50. Sarmiento JM, Thompson GB, Nagorney DM, et al. Pancreas-sparing duodenectomy for duodenal polyposis. Arch Surg. 2002;137:557-562; discussion 562-563.
51. Schonleben F, Qiu W, Allendorf JD, et al. Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas. J Gastrointest Surg. 2009; 13:1510-1516.
52. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch. 1994;425: 357-367.
53. Shibahara H, Tamada S, Goto M, et al. Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2004;28:327-338.
54. Sudo Y, Harada K, Tsuneyama K, et al. Oncocytic biliary cystadenocarcinoma is a form of intraductal oncocytic papillary neoplasm of the liver. Mod Pathol. 2001;14:1304-1309.
55. Tajiri T, Tate G, Kunimura T, et al. Histologic and immunohisto-chemical comparison of intraductal tubular carcinoma, intraductal papillary-mucinous carcinoma, and ductal adenocarcinoma of the pancreas. Pancreas. 2004;29:116-122.
56. Tajiri T, Tate G, Inagaki T, et al. Intraductal tubular neoplasms of the pancreas: histogenesis and differentiation. Pancreas. 2005;30: 115-121.
57. Takashima M, Ueki T, Nagai E, et al. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohis-tochemical expressions. Mod Pathol. 2000;13:1300-1307.
58. Tamada S, Goto M, Nomoto M, et al. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Pathol Int. 2002;52:713-723.
59. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
60. Tot T. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer. 2002;38:758-763.
61. Tot T. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7 - phenotype. Med Sci Monit. 2004;10:BR139-BR143.
62. Werling RW, Yaziji H, Bacchi CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303-310.
63. Yamaguchi K and, Enjoji M. Carcinoma of the ampulla of vater: a clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma. Cancer. 1987;59:506-515.
64. Yamaguchi H, Shimizu M, Ban S, et al. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2009;33:1164-1172.
65. Yonezawa S, Taira M, Osako M, et al. MUC-1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol Int. 1998;48:319-322.
66. Yonezawa S, Nakamura A, Horinouchi M, et al. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J Hepatobiliary Pancreat Surg. 2002;9:328-341.
67. Yonezawa S, Goto M, Yamada N, et al. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics. 2008;8:3329-3341.
68. Zalinski S, Paradis V, Valla D, et al. Intraductal papillary mucinous tumors of both biliary and pancreatic ducts. J Hepatol. 2007;46: 978-979.
69. Zen Y, Fujii T, Itatsu K, et al. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol. 2006;19:1243-1254.
70. Zen Y, Fujii T, Itatsu K, et al. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas. Hepatology. 2006;44:1333-1343.
71. Zen Y, Sasaki M, Fujii T, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct-an immunohisto-chemical study of 110 cases of hepatolithiasis. J Hepatol. 2006;44: 350-358.